An outbreak of Dipodascus capitatus infection in the ICU: Three case reports and review of the literature

Japanese Journal of Infectious Diseases

Volumn 57, Issue 6, 2004, Pages 248-252

  Ersoz, Gulden ^a   Otag, Feza ^a   Erturan, Zayre ^b   Aslan, Gonul ^a   Kaya, Ali ^a   Emekdas, Gürol ^a   Sugita, Takashi ^c  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CEFEPIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; CYTARABINE; FLUCONAZOLE; IMIPENEM; MITOXANTRONE; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; ARTICLE; ASPIRATION; BLOOD ANALYSIS; BONE MARROW EXAMINATION; CASE REPORT; CATHETER INFECTION; CHILDBIRTH; CLINICAL FEATURE; CROSS INFECTION; DIPODASCUS CAPITATUS; DISEASE COURSE; DRUG SUBSTITUTION; EPIDEMIC; FEMALE; FUNGUS IDENTIFICATION; GEOTRICHUM CAPITATUM; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; LABORATORY TEST; LUNG INFECTION; MALE; MORTALITY; MYCOSIS; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; PREGNANCY; SPUTUM ANALYSIS; URINALYSIS; URINARY TRACT INFECTION;

ADULT; AGED; CROSS INFECTION; DISEASE OUTBREAKS; DNA, FUNGAL; DNA, RIBOSOMAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYCOSES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SACCHAROMYCETALES;

EID: 13844317846     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Guého, E., de Hoog, G. S., Smith, M. T. and Meyer, S. A. (1987): DNA relatedness, taxonomy and medical significance of Geotrichum capitatum. J. Clin. Microbiol., 25, 1191-1194.
2. Girmenia, C., Pizzarelli, G., D'Antonio, D., Cristini, F. and Martino, P. (2003): In vitro susceptibility testing of Geotrichum capitatum: Comparison of the E-Test, disk diffusion, and sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method. Antimicrob. Agents Chemother., 47, 3985-3988.
3. National Committee for Clinical Laboratory Standards (2002): Reference methods for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
4. Makimura, K., Murayama, S. Y. and Yamaguchi, H. (1994): Detection of a wide range of medically important fungi by the polymerase chain reaction. J. Med. Microbiol., 40, 358-364.
5. Kurtzman, C. P. and Robnett, C. J. (1997): Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol., 35, 1216-1223.
6. Sugita, T., Takashima, M., Poonwan, N. et al. (2003): The first isolation of ustilaginomycetous anamorphic yeasts, Pseudozyma species, from patients' blood and a description of two new species: P. parantarctica and P. thailandica. Microbiol. Immunol., 47, 183-190.
7. Buchta, V., Zak, P., Kohout, A. and Otcenasek, M. (2001): Case report. disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia. Mycoses, 44, 505-512.
8. Fouassier, M., Joly, D., Cambon, M., Peigue-Lafeuille, H. and Condat, P.,(1998): Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature. Rev. Med. Interne, 19, 431-433.
9. Farina, C., Vailati, F., Manisco, A. and Goglio, A. (1999): Fungaemia survey: a 10-year experience in Bergamo, Italy. Mycoses, 42, 543-548.
10. Girmenia, C., Micozzi, A., Venditti, M., Meloni, G., Iori, A. P., Bastianello, S. and Martino, P. (1991): Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur. J. Clin. Microbiol. Infect. Dis., 10, 752-756.
11. Bouza, E. and Munoz, P. (2004): Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin. Microbiol. Infect., 10, 76-85.
12. Mahul, P., Piens, M. A., Guyotat, D., Godard, J., Archimbaud, E., Bui-Xuan, B. and Motin, J. (1989): Disseminated Geotrichum capitatum infection in a patient with acute myeloid leukemia. Mycoses, 32, 573-577.
13. Martino, P., Venditti, M., Micozzi, A., Morace, G., Polonelli, L., Mantovani, M. P., Petti, M. C., Burgio, V. L., Santini, C., Serra, P. et al. (1990): Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev. Infect. Dis., 12, 570-582.
14. Schiemann, R., Glasmacher, A., Bailly, E., Horre, R., Molitor, E., Leutner, C., Smith, M. T., Kleinschmidt, R., Marklein, G. and Sauerbruch, T. (1998): Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature. Mycoses, 41, 113-116.
15. Fridkin, S. K. and Jarvis, W. R. (1996): Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev., 9, 499-511.
16. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J. F., Patterson, T. F., Ritter, J., Selleslag, D., Shah, P. M., Stevens, D. A. and Walsh, T. J., Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (2002): Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis., 34, 7-14.
17. Maertens, J., Vrebos, M. and Boogaerts, M. (2001): Assessing risk factors for systemic fungal infections. Eur. J. Cancer Care (Engl), 10, 56-62.
18. Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., Lister, J. and Anaissie, E. J. (1998): Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis., 26, 1383-1396.
19. Brajtburg, J. and Bolard, J. (1996): Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev., 9, 512-531.
20. Olek, E. and Sugar, A. M. (1999): Amphotericin B. p. 1139-1151. In Yu, V. L., Merigan, T.C., Jr. and Barriere, S.L. (eds.), Antimicrobial Therapy and Vaccines. Williams and Wilkins, Pa.